1.
|
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: EFC6125, EudraCT : 2005-005026-31, AVE0005A /3001, NCT00327444
|
|
2.
|
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: ARD6123, AVE0005B/2001, NCT00284141
|
|
3.
|
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: ARD6122, AVE0005, NCT00327171
|
|
4.
|
Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCCTG-N0537, N0537, NCT00369655
|
|
5.
|
Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NABTC-0601, NCT00369590
|
|
6.
|
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: PMH-PHL-050, 7498, NCI-7498, NCT00407654
|
|
7.
|
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: CCC-PHII-76, 7533, NCT00407485
|
|
8.
|
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: ARD6772, EUDRACT: 2006-000604-16, NCT00396591
|
|
9.
|
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: CCC-PHII-77, 7522, NCT00450255
|
|
10.
|
Phase: Phase I
Type: Treatment
Status: Completed
Age: 25 and over
Sponsor: NCI, Pharmaceutical / Industry
Protocol IDs: MSKCC-01131, REGENERON-VGFT-ST-0103, NCI-G02-2065, NCT00036946
|
|
11.
|
Phase: Phase I
Type: Treatment
Status: Closed
Age: 25 and over
Sponsor: NCI, Pharmaceutical / Industry
Protocol IDs: MSKCC-02020, REGENERON-VGF-ST-0105, NCI-G-02-2101, NCT00045266
|
|
12.
|
Phase: Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI, Pharmaceutical / Industry
Protocol IDs: MSKCC-03138, REGENERON-VGFT-ST-0304, NCT00082823
|
|
13.
|
Phase: Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI, Pharmaceutical / Industry
Protocol IDs: MSKCC-03137, REGENERON-VGFT-ST-0202, NCT00083213
|
|
14.
|
Phase: Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: TCD10173, EudraCT 2007-003737-16, NCT00644124
|
